Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-054570
Filing Date
2019-10-30
Accepted
2019-10-30 20:12:57
Documents
2
Period of Report
2019-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1533
2 POA DOCUMENT poa.txt EX-24.3_877521 3175
  Complete submission text file 0001209191-19-054570.txt   6168
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Robbins Wendye (Reporting) CIK: 0001791244 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38997 | Film No.: 191181668